The Future of AI in Healthcare Depends on Clinical Data Quality Assessment
[Sponsored] Clinical Architecture Founder and CEO Charlie Harp talked about how clinical data can be…
The Future of AI in Healthcare Depends on Clinical Data Quality Assessment
[Sponsored] Clinical Architecture Founder and CEO Charlie Harp talked about how clinical data can be assessed and improved to build trust from the healthcare industry. The post The Future of AI in Healthcare Depends on Clinical Data Quality Assessment appeared first on MedCity News.
Wary of RFK Jr., Colorado Started Revamping Its Vaccine Policies in the Spring
As Health and Human Services Secretary Robert F. Kennedy Jr.’s dismantling of federal vaccine policy continues to roil the Centers for Disease Control and Prevention, some Democratic-led states have struck out on their own, setting up new systems to help them assess the science and maintain immunization access for their residents. Four western states —…
Inside a Big Q3: Venture Capital for Digital Health Continues to Grow
Digital health funding remains strong so far this year, with $9.9 billion raised through Q3 and megarounds driving record deal sizes. However, the path to scale is becoming less predictable, as startups increasingly rely on unlabeled rounds and face longer timelines to reach Series B. The post Inside a Big Q3: Venture Capital for Digital…
CertifyOS Unveils Provider Data Platform to Streamline Operations and Cut Costs
CertifyOS launched Provider Hub, an AI-powered platform that helps payers unify provider data and reduce administrative costs. The post CertifyOS Unveils Provider Data Platform to Streamline Operations and Cut Costs appeared first on MedCity News.
Why Democrats Are Casting the Government Shutdown as a Health Care Showdown
Hours into the federal government shutdown, Julio Fuentes stood steps from the U.S. Capitol to deliver an urgent message about the Hispanic voting bloc that helped the GOP sweep into power last year. Those votes, he cautioned, are at risk if Congress doesn’t pass a law to preserve lower premiums on Affordable Care Act marketplace…
Skye Bio Obesity Drug Fails in Phase 2; Hopes Now Ride on Higher Doses and Combo Treatment
While Skye Bioscience said its drug nimacimab may yet achieve better weight loss results with higher doses, the company and analysts are interested in the drug’s potential to be combined with Novo Nordisk’s Wegovy. Skye’s drug is an antibody designed to preferentially target CB1 receptors in the gut, offering an alternative approach to activating GLP-1…
Steps or Surgery: The Case for Wearables
Relentlessly, rates of chronic disease, depression, and medication use continue to rise — if there were ever a time to implement alternative preventive health tools in clinical practice, now is certainly it. The post Steps or Surgery: The Case for Wearables appeared first on MedCity News.
Steps or Surgery: The Case for Wearables
Relentlessly, rates of chronic disease, depression, and medication use continue to rise — if there were ever a time to implement alternative preventive health tools in clinical practice, now is certainly it. The post Steps or Surgery: The Case for Wearables appeared first on MedCity News.
The Tariff Opportunity for Medtech: Building the Supply Chain of the Future
The current tariff volatility creates a new set of challenges for medtech companies, but uncertainty is here to stay. Companies must act now, building on the trade compliance capabilities they are building to create a resilient supply chain that is ready for future disruptions. The post The Tariff Opportunity for Medtech: Building the Supply Chain…
The Tariff Opportunity for Medtech: Building the Supply Chain of the Future
The current tariff volatility creates a new set of challenges for medtech companies, but uncertainty is here to stay. Companies must act now, building on the trade compliance capabilities they are building to create a resilient supply chain that is ready for future disruptions. The post The Tariff Opportunity for Medtech: Building the Supply Chain…
